
Episodes

4 days ago
4 days ago
Creative Biolabs is pleased to Dr. Bruce Walcheck to explore dual-function multi-engager antibodies targeting NK cells and tumor cells, revealing how TABK technology enhances cancer immunotherapy through innovative recombinant antibody approaches.
Version: 20241125
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.